Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Real-world experience of the Sentinel cerebral protection device: Insights from the FDA Manufacturer and User Facility Device Experience (MAUDE) database.

Case BC, Forrestal BJ, Yerasi C, Khan JM, Khalid N, Shlofmitz E, Chen Y, Musallam A, Chezar-Azerrad C, Satler LF, Ben-Dor I, Rogers T, Waksman R.

Cardiovasc Revasc Med. 2019 Nov 22. pii: S1553-8389(19)30760-2. doi: 10.1016/j.carrev.2019.11.014. [Epub ahead of print]

PMID:
31780421
2.

Analysis of the Food and Drug Administration manufacturer and user facility device experience database for patient- and circuit-related adverse events involving extracorporeal membrane oxygenation.

Khalid N, Javed H, Ahmad SA, Edelman JJ, Shlofmitz E, Chen Y, Musallam A, Rogers T, Hashim H, Bernardo NL, Waksman R.

Cardiovasc Revasc Med. 2019 Nov 20. pii: S1553-8389(19)30757-2. doi: 10.1016/j.carrev.2019.11.011. [Epub ahead of print]

PMID:
31767523
3.

Racial Disparities in Clinical Characteristics and Outcomes of Women Undergoing Percutaneous Coronary Intervention.

Iantorno M, Rogers T, Torguson R, Kolm P, Gajanana D, Khalid N, Shlofmitz E, Khan JM, Chen Y, Musallam A, Weintraub WS, Waksman R.

Cardiovasc Revasc Med. 2019 Dec;20(12):1039-1042. doi: 10.1016/j.carrev.2019.09.020. Epub 2019 Oct 22.

PMID:
31678115
4.

Trends in Death Rate 2009 to 2018 Following Percutaneous Coronary Intervention Stratified by Acuteness of Presentation.

Gajanana D, Weintraub WS, Kolm P, Rogers T, Iantorno M, Ben-Dor I, Khalid N, Shlofmitz E, Khan JM, Chen Y, Musallam A, Kajita AH, Hashim H, Satler LF, Torguson R, Waksman R.

Am J Cardiol. 2019 Nov 1;124(9):1349-1356. doi: 10.1016/j.amjcard.2019.07.059. Epub 2019 Aug 14.

PMID:
31547993
5.

Low-risk Non-ST-Elevation Acute Coronary Syndrome and Normal Troponin: Do We Need Further Evaluation?

Marcusohn E, Epstein D, Musallam A, Keidar Z, Roguin A.

Isr Med Assoc J. 2019 Sep;21(9):603-606.

6.

Adverse Events Related to Orbital Atherectomy: Lessons Learned from an Analytic Review of the MAUDE Database.

Khalid N, Javed H, Rogers T, Hashim H, Shlofmitz E, Wermers JP, Chen Y, Musallam A, Khan JM, Torguson R, Bernardo NL, Waksman R.

EuroIntervention. 2019 Aug 20. pii: EIJ-D-19-00295. doi: 10.4244/EIJ-D-19-00295. [Epub ahead of print] No abstract available.

7.

Adverse Events Associated with the Use of Guide Extension Catheters during Percutaneous Coronary Intervention: Reports from the Manufacturer and User Facility Device Experience (MAUDE) database.

Chen Y, Shah AA, Shlofmitz E, Khalid N, Musallam A, Khan JM, Iantorno M, Gajanana D, Rogers T, Hashim H, Bernardo NL, Waksman R.

Cardiovasc Revasc Med. 2019 May;20(5):409-412. doi: 10.1016/j.carrev.2019.02.016. Epub 2019 Feb 18.

PMID:
31079818
8.

Blinding results for transcatheter mitral valve repair.

Khan JM, Musallam A, Waksman R.

Cardiovasc Revasc Med. 2019 Jun;20(6):530. doi: 10.1016/j.carrev.2019.03.012. Epub 2019 Mar 19. No abstract available.

PMID:
31000434
9.

Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database.

Khalid N, Javed H, Rogers T, Hashim H, Shlofmitz E, Chen Y, Khan JM, Musallam A, Torguson R, Bernardo NL, Waksman R.

Catheter Cardiovasc Interv. 2019 Jul 1;94(1):157-164. doi: 10.1002/ccd.28297. Epub 2019 Apr 15.

PMID:
30985082
10.

Adverse Events and Modes of Failure Related to Impella RP: Insights from the Manufacturer and User Facility Device Experience (MAUDE) Database.

Khalid N, Rogers T, Shlofmitz E, Chen Y, Musallam A, Khan JM, Iantorno M, Gajanana D, Hashim H, Torguson R, Bernardo N, Waksman R.

Cardiovasc Revasc Med. 2019 Jun;20(6):503-506. doi: 10.1016/j.carrev.2019.03.010. Epub 2019 Mar 16.

PMID:
30922871
11.

Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database.

Khalid N, Rogers T, Shlofmitz E, Chen Y, Khan JM, Musallam A, Iantorno M, Waksman R.

EuroIntervention. 2019 May 20;15(1):44-46. doi: 10.4244/EIJ-D-18-01021. No abstract available.

12.

Usefulness of Pelvic Radiation Protection Shields During Transfemoral Procedures-Operator and Patient Considerations.

Marcusohn E, Postnikov M, Musallam A, Yalonetsky S, Mishra S, Kerner A, Poliakov A, Roguin A.

Am J Cardiol. 2018 Sep 15;122(6):1098-1103. doi: 10.1016/j.amjcard.2018.06.003. Epub 2018 Jun 21.

PMID:
30057233
13.

Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients.

Bove R, Healy BC, Musallam A, Soltany P, Diaz-Cruz C, Sattarnezhad N, Glanz BI, Kivisäkk P, Miller KK, Chitnis T.

Mult Scler. 2019 Mar;25(3):344-351. doi: 10.1177/1352458517750768. Epub 2018 Jan 11.

PMID:
29320952
14.

Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity.

Bove R, Musallam A, Xia Z, Baruch N, Messina S, Healy BC, Chitnis T.

Mult Scler Relat Disord. 2016 Jul;8:136-40. doi: 10.1016/j.msard.2016.05.019. Epub 2016 May 31.

PMID:
27456889
15.

Effect of Modifying Antiplatelet Treatment to Ticagrelor in High-Risk Coronary Patients With Low Response to Clopidogrel (MATTIS).

Musallam A, Orvin K, Perl L, Mosseri M, Arbel Y, Roguin A, Lev EI.

Can J Cardiol. 2016 Oct;32(10):1246.e13-1246.e19. doi: 10.1016/j.cjca.2015.11.023. Epub 2015 Dec 9.

PMID:
26971236
16.

Effect of vitamin D on MS activity by disease-modifying therapy class.

Rotstein DL, Healy BC, Malik MT, Carruthers RL, Musallam AJ, Kivisakk P, Weiner HL, Glanz B, Chitnis T.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 29;2(6):e167. doi: 10.1212/NXI.0000000000000167. eCollection 2015 Dec.

17.

Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.

Bove R, Healy BC, Musallam A, Glanz BI, De Jager PL, Chitnis T.

Mult Scler. 2016 Jun;22(7):935-43. doi: 10.1177/1352458515606211. Epub 2015 Oct 7.

18.

Coronary artery aneurysm following drug-coated balloon treatment.

Solomonica A, Musallam A, Roguin A.

Cardiovasc Revasc Med. 2015 Dec;16(8):505-7. doi: 10.1016/j.carrev.2015.08.001. Epub 2015 Aug 12.

PMID:
26349442
19.

Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.

Baruch NF, O'Donnell EH, Glanz BI, Benedict RH, Musallam AJ, Healy BC, Rintell D, Chitnis T.

Mult Scler. 2016 Mar;22(3):354-61. doi: 10.1177/1352458515588781. Epub 2015 Jun 3.

PMID:
26041802
20.

Clinical and MRI phenotype of children with MOG antibodies.

Fernandez-Carbonell C, Vargas-Lowy D, Musallam A, Healy B, McLaughlin K, Wucherpfennig KW, Chitnis T.

Mult Scler. 2016 Feb;22(2):174-84. doi: 10.1177/1352458515587751. Epub 2015 Jun 3.

21.

Response to comment on "a randomized study comparing the use of a pelvic lead shield during trans-radial interventions: Threefold decrease in radiation to the operator but double exposure to the patient".

Roguin A, Musallam A, Rappaport B.

Catheter Cardiovasc Interv. 2015 Nov;86(5):960. doi: 10.1002/ccd.25918. Epub 2015 Apr 24. No abstract available.

PMID:
25914301
22.

Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years.

Benson LA, Healy BC, Gorman MP, Baruch NF, Gholipour T, Musallam A, Chitnis T.

Mult Scler Relat Disord. 2014 Mar;3(2):186-93. doi: 10.1016/j.msard.2013.06.004. Epub 2013 Jul 12.

PMID:
25878006
23.

A randomized study comparing the use of a pelvic lead shield during trans-radial interventions: Threefold decrease in radiation to the operator but double exposure to the patient.

Musallam A, Volis I, Dadaev S, Abergel E, Soni A, Yalonetsky S, Kerner A, Roguin A.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1164-70. doi: 10.1002/ccd.25777. Epub 2015 Feb 3.

PMID:
25510441
24.

Treatment satisfaction in multiple sclerosis.

Glanz BI, Musallam A, Rintell DJ, Chitnis T, Weiner HL, Healy BC.

Int J MS Care. 2014 Summer;16(2):68-75. doi: 10.7224/1537-2073.2013-021.

25.

Stent thrombosis in a patient with high on-treatment platelet reactivity despite ticagrelor treatment.

Musallam A, Lev EI, Roguin A.

Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):85-7. doi: 10.1177/2048872614534563. Epub 2014 May 22.

PMID:
24855285
26.

Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis.

Malik MT, Healy BC, Benson LA, Kivisakk P, Musallam A, Weiner HL, Chitnis T.

Neurology. 2014 Jun 17;82(24):2173-9. doi: 10.1212/WNL.0000000000000524. Epub 2014 May 21.

27.
28.

Low testosterone is associated with disability in men with multiple sclerosis.

Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller KK, Chitnis T.

Mult Scler. 2014 Oct;20(12):1584-92. doi: 10.1177/1352458514527864. Epub 2014 Apr 7.

29.

Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.

Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N, Zivadinov R; U.S. Network of Pediatric MS Centers of Excellence.

BMC Neurol. 2013 Nov 13;13:173. doi: 10.1186/1471-2377-13-173.

30.

Increased leptin and A-FABP levels in relapsing and progressive forms of MS.

Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T.

BMC Neurol. 2013 Nov 11;13:172. doi: 10.1186/1471-2377-13-172.

31.

No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.

Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S, Guttmann CR, De Jager PL, Chitnis T.

BMC Neurol. 2013 Jul 3;13:73. doi: 10.1186/1471-2377-13-73.

32.

Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.

Healy BC, Engler D, Glanz B, Musallam A, Chitnis T.

Mult Scler Int. 2013;2013:189624. doi: 10.1155/2013/189624. Epub 2013 Mar 10.

33.

Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course.

Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, Greeke E, Weiner HL, Chitnis T, Wicks P, De Jager PL.

PLoS One. 2013;8(3):e59707. doi: 10.1371/journal.pone.0059707. Epub 2013 Mar 20.

34.

Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.

Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL.

Ann Neurol. 2013 Jun;73(6):729-40. doi: 10.1002/ana.23880. Epub 2013 Jul 8.

PMID:
23494648
35.

Effect of gender on late-onset multiple sclerosis.

Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T.

Mult Scler. 2012 Oct;18(10):1472-9. Epub 2012 Mar 1.

PMID:
22383227
36.

Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction.

Bahouth F, Mutlak D, Furman M, Musallam A, Hammerman H, Lessick J, Dabbah S, Reisner S, Agmon Y, Aronson D.

Heart. 2010 May;96(9):683-8. doi: 10.1136/hrt.2009.183822.

PMID:
20424149
37.

Impact of diastolic dysfunction on the development of heart failure in diabetic patients after acute myocardial infarction.

Aronson D, Musallam A, Lessick J, Dabbah S, Carasso S, Hammerman H, Reisner S, Agmon Y, Mutlak D.

Circ Heart Fail. 2010 Jan;3(1):125-31. doi: 10.1161/CIRCHEARTFAILURE.109.877340. Epub 2009 Nov 12.

PMID:
19910536
38.
39.

Nursing in Jordan.

MUSALLAM A.

Am J Nurs. 1958 Sep;58(9):1249-51. No abstract available.

PMID:
13559302

Supplemental Content

Loading ...
Support Center